Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcom
about
Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache SocietyEpilepsy during pregnancy: focus on management strategiesClinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosisCongenital Anomalies in Children of Mothers Taking Antiepileptic Drugs with and without Periconceptional High Dose Folic Acid Use: A Population-Based Cohort StudyWomen with epilepsy: clinically relevant issuesFoetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age.Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years.Hormonal aspects of epilepsy.Carbamazepine clearance and seizure stability during pregnancy.Another nail in the coffin.Antiepileptic drugs in women with epilepsy during pregnancyTreatment of paroxysmal dyskinesias.Teratogenic effects of antiepileptic drugsThe treatment of women with epilepsy.Effects of breastfeeding in children of women taking antiepileptic drugsThe Devil Is in the Details: Not All AED-Associated Major Congenital Malformations Are EqualAntiepileptic drug use by pregnant women enrolled in Florida Medicaid.Fetal antiepileptic drug exposure: motor, adaptive, and emotional/behavioral functioning at age 3 years.Seizure occurrence, pregnancy outcome among women with active convulsive epilepsy: one year prospective studyKnowledge and practice profile of obstetricians regarding epilepsy in women in Kerala state, IndiaAntidepressants and the developing nervous systemCognitive outcomes of prenatal antiepileptic drug exposure.Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years.Apgar-score in children prenatally exposed to antiepileptic drugs: a population-based cohort study.Differential effects of antiepileptic drugs on neonatal outcomes.Incidence of cleft lip and palate in gorgan - northern iran: an epidemiological study.Mortality and Morbidity During Delivery Hospitalization Among Pregnant Women With Epilepsy in the United StatesNeurological and psychiatric sequelae of developmental exposure to antiepileptic drugs.Use of antiepileptic medications in pregnancy in relation to risks of birth defectsNeuroendocrine considerations in the treatment of men and women with epilepsyExposure to antiepileptic drugs in utero and child development: a prospective population-based study.In utero valproate exposure and autism: long suspected, finally provenFetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years.Teratogenicity of Antiepileptic Drugs.Neurological Disorders Complicating Pregnancy - Focus on Obstetric Outcome.Antiepileptic drugs prescribed in pregnancy and prevalence of major congenital malformations: comparative prevalence studies.Is head trauma a risk factor for amyotrophic lateral sclerosis? An evidence based review.An update in the treatment of neurologic disorders during pregnancy--focus on migraines and seizures.Evaluation of a Decision Aid for Women with Epilepsy Who Are Considering Pregnancy: A Randomized Controlled Trial.
P2860
Q24633523-121CFDEF-3996-47A2-9D01-279AA1F0ACB7Q28080299-2785140C-67E4-406B-A8C3-5B946C9D4643Q28392768-915AED57-12E9-41E8-A8C6-A64201668FD2Q28546202-ADEAA850-7552-4983-A302-8927A018A241Q30245064-E5EE7E3B-0192-4115-AAE6-A4064D62BF9FQ30498029-C553D0B8-E053-4733-A974-33BCE73EA34BQ30540714-D7106495-78C9-4677-AB17-50BC6A7E0980Q30585915-6507B11B-85A7-47FD-B662-7156146A8236Q33638313-2147953D-C47F-4DF5-BA8E-F3C2D5EAFAA1Q33696210-78201288-CBF8-4719-8367-EC55EF9A551DQ33864996-09A972B4-806C-4A3D-9471-8F1097D23063Q33949402-9C35CD12-A3A4-4467-A4FE-9EB572F56C35Q34151861-88444E72-3BCA-429E-8130-0254AB156A08Q34267151-E5555881-BBA7-498E-9B66-FE9FF20ABF0AQ34363064-2F0886FC-22D0-42B9-BF44-195305D1E1D2Q34458170-31338F30-8D6B-4916-8CB6-38BAF4673394Q35052150-09037402-110B-48BB-838C-A78AD20A3716Q35153696-223CB438-C3CD-46C2-8ABB-EE79D3FEEBB6Q35256170-60C848F5-74B1-4067-BE3D-742A4E187742Q35275765-6D0B7ED1-650B-47C5-888B-77BCCD19A374Q35430420-E02051BC-EFA0-43AD-800C-CF99636D44E9Q35640416-0376602D-1B7F-4372-9002-B614434FA8D9Q35762249-3BCD7D49-EF2F-4FC2-A6A0-D6909A0DE53CQ35883207-0A07FB65-40CB-44BF-84F8-82F334FB003CQ36053674-329EF1E6-B9B8-4F69-8265-C464DB95DD5FQ36353155-4A3830C5-C1B6-48A3-AF37-714D28C4F012Q36447429-8C59C272-C269-4778-AA52-2A90F5B8499AQ36486000-8FD2BDF2-031D-4502-9F95-E48ADEC6AE20Q36490198-804CD5CE-E8BD-4EBF-8FC5-3EC27731814CQ36751405-900AEF14-F4E6-4076-9A1E-B4F14EDF4219Q37055791-374C1984-C43A-48F7-BCE8-1569AE897BD4Q37153982-327D187D-1CFD-4846-A3BD-FC665A8D20DBQ37372246-8F536CA0-3026-4161-98B3-659C37AED0E5Q37515864-15A9D4F7-88B3-4135-B7D3-2D20BC3F7EDDQ37623101-E04D2785-0790-44AF-9AEF-79ACBE54862BQ37630116-23242206-FE5F-4BA3-ABD2-F233A61A3E3BQ37652826-08A1A037-27D7-4E8A-AAD2-6745D171B886Q37994257-48CBC0A2-A6BB-484F-ADE8-1A67B52D0FE9Q38006916-C28B9533-2706-4BD8-93CF-8BB650A4DE27Q38673714-9BA95367-5E79-47B7-9109-70BE405E18F0
P2860
Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcom
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Practice parameter update: man ...... d Technology Assessment Subcom
@ast
Practice parameter update: man ...... d Technology Assessment Subcom
@en
type
label
Practice parameter update: man ...... d Technology Assessment Subcom
@ast
Practice parameter update: man ...... d Technology Assessment Subcom
@en
prefLabel
Practice parameter update: man ...... d Technology Assessment Subcom
@ast
Practice parameter update: man ...... d Technology Assessment Subcom
@en
P2093
P2860
P1433
P1476
Practice parameter update: man ...... d Technology Assessment Subcom
@en
P2093
A Krumholz
A N Wilner
American Academy of Neurology
American Epilepsy Society
B S Koppel
C A Hovinga
C L Harden
P2860
P304
P356
10.1212/WNL.0B013E3181A6B312
P407
P577
2009-04-27T00:00:00Z